|
2020
|
Invention
|
Method of controlling progression of hyperparathyroidism with calcifediol, and compositions for u... |
|
2019
|
Invention
|
Oxyntomodulin peptide analog formulations.
The present invention relates to GLP-1 and/or glucago... |
|
|
Invention
|
Methods of treatment with mixed metal compounds. A method treating and/or preventing vascular cal... |
|
|
Invention
|
Vitamin d pediatric dosage forms, methods of making and using. Pediatric and modified release dos... |
|
|
Invention
|
Use of calcifediol in bariatric surgery patients. Methods and compositions for treating bariatric... |
|
2018
|
Invention
|
1-deoxy analogs of vitamin d-related compounds.
This present disclosure is directed to novel pro... |
|
2017
|
Invention
|
Tetrahydrocyclopenta[b]indole compounds and phosphodiesterase inhibitors for the treatment of the... |
|
|
Invention
|
Methods of vitamin d treatment. Methods for treating vitamin D insufficiency and secondary... |
|
|
Invention
|
Methods of vitamin d treatment. Methods for treating vitamin D insufficiency and secondary hyperp... |
|
2016
|
Invention
|
Method of using composition comprising mixed metal compounds and xanthan gum.
The present invent... |
|
|
Invention
|
Methods and compounds for vitamin d therapy.
Methods and compositions comprising 1,25-dihydroxyv... |
|
|
Invention
|
Adjunctive therapy with 25-hydroxyvitamin d and articles therefor. Methods, compositions, and kit... |
|
2015
|
Invention
|
Adjunctive therapy with 25-hydroxyvitamin d. Methods, compositions, and kits for adjunctive thera... |
|
2014
|
Invention
|
Stabilized modified release vitamin d formulation and method of administring same. A stabilized f... |
|
2013
|
Invention
|
Metal compounds mixed or sulphated, as phosphate binders. A mixed metal compound for pharmaceutic... |
|
2011
|
Invention
|
Pharmaceutically active compounds, their manufacture, compositions containing them, and their use... |
|
|
Invention
|
Composition comprising mixed metal compounds and xanthan gum. The present invention provides a co... |
|
|
Invention
|
1-deoxy analogs of 1,25-dihydroxyvitamin d3 compounds. This present disclosure is directed to nov... |
|
2010
|
Invention
|
Metal compounds, mixed or sulphated, as phosphate binders. A mixed metal compound for pharmaceuti... |
|
|
Invention
|
Phosphate management with small molecules. This invention relates to methods and small molecules ... |
|
2009
|
Invention
|
Method for synthesizing vitamin d analogs.
Processes for preparing vitamin D2 derivatives and in... |
|
|
Invention
|
P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof.
T... |
|
2008
|
Invention
|
Mixed metal compounds for treatment of hyperphosphataemia. a wherein M″ is at least one bivalent ... |
|
|
Invention
|
Mixed metal compounds used as antacids. n− at least one n-valent anion; 2+a=2b+Σcn and Σcn<0.9a, ... |
|
|
Invention
|
Methods and compounds for vitamin d therapy. 2 to lower or maintain lowered serum parathyroid hor... |
|
2007
|
G/S
|
Chemicals for use in science and the pharmaceutical industry; chemicals for use in the manufactur... |
|
2006
|
G/S
|
Phosphate binders for use in the treatment of hyperphosphataemia; magnesium iron hydroxy carbonat... |
|
|
Invention
|
P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof. Th... |
|
|
Invention
|
3 compounds. 3, for example, cell-proliferative disorders. |
|
|
Invention
|
3. The present invention provides novel 16,23-diene 25-oxime ether analogs of 1,25-dihydroxy vita... |
|
2003
|
Invention
|
3. 3, for example, cell-proliferative disorders. |
|
|
Invention
|
P450rai-2(p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof. The... |
|
|
Invention
|
24-sulfoximine vitamin d3 compounds. 3, for example, cell-proliferative disorders. |
|
|
Invention
|
Thymus expressed human cytochrome p450(p450tec). The present invention relates to a novel human g... |
|
2002
|
Invention
|
Low-calcemic oxime analogs of 1α,25-dihydroxy vitamin d3. 3, for example, cell-proliferative diso... |
|
|
Invention
|
24-sulfur-substituted analogs of 1alpha, 25-dihydroxy vitamin d3. The present invention provides ... |
|
|
Invention
|
Retinoic acid metabolizing cytochrome p450. The present invention provides a novel retinoic acid ... |
|
2000
|
Invention
|
Cytochrome p450rai-2 and related proteins. The present invention provides a novel all-trans-RA in... |
|
|
Invention
|
Metal compounds, mixed or sulphated, as phosphate binders. A non-aluminum containing mixed metal ... |
